GOLF insider files Form 144 to sell 20,000 common shares
Rhea-AI Filing Summary
A shareholder of GOLF filed a Form 144 notice to sell up to 20,000 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an approximate aggregate market value of $1,693,162.05. The filing notes that there were 58,661,329 shares outstanding at the time of the notice. These shares were acquired on 03/07/2023 through restricted stock vesting from the issuer as compensation, with the same date listed as the payment date. The signer represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
Positive
- None.
Negative
- None.
FAQ
What does GOLF's latest Form 144 filing disclose?
The Form 144 filing for GOLF discloses a planned sale of up to 20,000 shares of common stock on the NYSE through Fidelity Brokerage Services LLC, with an approximate aggregate market value of $1,693,162.05.
How many GOLF shares are planned to be sold under this Form 144?
The notice covers a proposed sale of 20,000 shares of GOLF common stock, as listed in the section "Number of Shares or Other Units To Be Sold."
How were the GOLF shares in the Form 144 acquired?
The 20,000 shares were acquired on 03/07/2023 via restricted stock vesting from the issuer, with the nature of payment described as compensation.
What is the aggregate market value of the GOLF shares to be sold?
The Form 144 states an aggregate market value of approximately $1,693,162.05 for the 20,000 GOLF common shares to be sold.
When is the approximate sale date for the GOLF shares in this Form 144?
The filing lists an approximate date of sale of 11/25/2025 for the 20,000 GOLF common shares.
How many GOLF shares are outstanding according to this Form 144?
The Form 144 indicates that there were 58,661,329 shares of the issuer’s common stock outstanding at the time of the notice.
What representation does the seller make about information on GOLF?
By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.